CRISPR Therapeutics AG - Common Shares (CRSP)
40.97
0.00 (0.00%)
Crispr Therapeutics is a biopharmaceutical company that focuses on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene editing technology
The company aims to harness the potential of genetic editing to treat various conditions, including genetic disorders, cancer, and autoimmune diseases. Through a combination of innovative research and strategic collaborations, Crispr Therapeutics is dedicated to advancing its pipeline of therapies and ultimately improving patient outcomes and quality of life.
| Previous Close | 40.97 |
|---|---|
| Open | - |
| Bid | 41.06 |
| Ask | 41.50 |
| Day's Range | N/A - N/A |
| 52 Week Range | 36.52 - 75.91 |
| Volume | 500 |
| Market Cap | 3.23B |
| PE Ratio (TTM) | -9.418 |
| EPS (TTM) | -4.4 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 2,159,356 |
